Helicobacter pylori infection

Search with Google Search with Bing
Information
Disease name
Helicobacter pylori infection
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05749081 Active, not recruiting Phase 4 Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy May 13, 2023 July 2024
NCT05647278 Active, not recruiting Phase 4 A RCT of the Efficacy of Tegoprazan 50mg QD in the Treatment of Helicobacter Pylori Infection ( TATH-1 ) November 1, 2022 December 31, 2024
NCT03541876 Active, not recruiting French Pediatric Helicobacter Pylori Observatory January 9, 2018 February 2024
NCT02407119 Active, not recruiting Phase 3 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD June 2003 June 2030
NCT02112214 Active, not recruiting Phase 3 Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population June 2014 December 2029
NCT01678027 Active, not recruiting Phase 3 Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication November 2004 December 2035
NCT06396780 Active, not recruiting Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy March 30, 2024 March 31, 2025
NCT05631015 Active, not recruiting Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals January 1, 2012 December 31, 2023
NCT00825630 Completed Phase 4 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors) November 2008 November 2009
NCT00841490 Completed Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults September 2008 May 2012
NCT00854451 Completed Phase 4 Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection August 1996 February 1998
NCT00867867 Completed Phase 1 Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries October 2003 June 2008
NCT01032655 Completed Phase 4 The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection April 2009 March 2012
NCT01061437 Completed Phase 3 S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori) June 2009 July 2011
NCT05431075 Completed Phase 4 Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses July 1, 2022 February 1, 2024
NCT00202488 Completed Phase 2/Phase 3 The Effect of H. Pylori Infection on Iron Metabolism November 2002 September 2007
NCT00284700 Completed N/A Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh? December 1997 May 2001
NCT00403364 Completed Phase 2/Phase 3 Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial July 2003 February 2006
NCT00467571 Completed Phase 4 Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura March 2006 December 2008
NCT00719420 Completed Phase 3 Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia April 2006 February 2007
NCT00736476 Completed Phase 1 Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults October 2008 April 2010
NCT00772837 Completed N/A Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms August 2006 January 2009
NCT01085786 Completed Phase 4 Sequential and Hybrid Therapies for H Pylori Infection August 2008 May 2010
NCT01131026 Completed Phase 3 Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication June 2010 August 2011
NCT01168063 Completed N/A Molecular Detection of Antibiotic Resistance and H Pylori Eradication February 2010 March 2013
NCT01306786 Completed N/A Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication November 2008 February 2011
NCT01453036 Completed Phase 4 Clarithromycin Resistant Tailored Therapy August 2011 June 2012
NCT01456728 Completed Phase 3 Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors January 2011 September 2013
NCT01512875 Completed S1119 Peruvian H. Pylori Water Contamination Study December 2011 November 2013
NCT01544517 Completed Phase 3 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection January 2011 December 2011
NCT01573975 Completed Phase 4 Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori January 2009 May 2011
NCT01593592 Completed N/A Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients June 2012
NCT01730352 Completed Phase 2/Phase 3 Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients October 2008 March 2012
NCT01735136 Completed N/A Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection November 21, 2012 July 25, 2013
NCT01760824 Completed N/A Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication May 2011 December 2012
NCT01769365 Completed Phase 4 Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection July 2010 October 2013
NCT01887249 Completed Phase 4 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea May 2010 July 2013
NCT01933659 Completed Phase 3 Anti-H. Pylori Effect of Deep See Water September 2013 February 2014
NCT01967329 Completed Phase 4 CANHelp Working Group Treatment Trials November 2008 May 2019
NCT01969331 Completed Phase 4 Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori December 2008 December 2010
NCT01980095 Completed Phase 3 ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 November 2013 August 2015
NCT02010112 Completed Phase 3 Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori January 2014 February 2015
NCT02108704 Completed N/A Helicobacter Pylori Eradication Study in Parkinson's Disease December 2013 May 2016
NCT02159976 Completed N/A Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea July 2014 April 2016
NCT02359435 Completed N/A Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection October 2012 February 2015
NCT02359942 Completed N/A The Diagnostic Validity of the Urea Breath Test March 1, 2015 December 31, 2018
NCT02466919 Completed Phase 4 Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients May 2014 September 2016
NCT02483715 Completed Phase 4 Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection July 2015 May 2018
NCT02490839 Completed Phase 4 Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection July 2015 January 2019
NCT02528721 Completed Phase 3 Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection October 2015 July 2016
NCT02541786 Completed Phase 4 Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection January 2015 August 2015
NCT02541864 Completed N/A Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication July 2013 August 2015
NCT02547012 Completed N/A Comparison of Two Rescue Therapies for Helicobacter Pylori Infection November 2013 October 2017
NCT02547025 Completed N/A Personalized Treatment for Refractory H Pylori Infection August 1, 2012 October 31, 2021
NCT02547038 Completed N/A Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy February 2015 October 2018
NCT02557932 Completed Phase 3 Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication September 2015 September 28, 2019
NCT02596620 Completed N/A Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication October 2013 November 2015
NCT02646332 Completed N/A Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy December 2015 August 31, 2020
NCT02691637 Completed Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients February 2006 December 2022
NCT02732249 Completed Phase 4 Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment April 1, 2016 September 30, 2017
NCT02803216 Completed Phase 1/Phase 2 Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori January 2013 April 2016
NCT02873247 Completed Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori September 2015 June 2017
NCT02894892 Completed N/A Intragastric pH and Bismuth Effect for H. Pylori Eradication November 15, 2016 February 20, 2019
NCT02905825 Completed Phase 3 Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics May 18, 2017 November 5, 2017
NCT02925091 Completed Primary Antimicrobial Resistance Patterns of Austrian Helicobacter Pylori Clinical Isolates February 2015
NCT02935010 Completed Phase 4 Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment February 5, 2017 March 31, 2018
NCT02945137 Completed Optimal Site for Rapid Urease Test in the Stomach January 2016 December 2017
NCT02959255 Completed Phase 4 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection January 30, 2017 December 30, 2017
NCT02978157 Completed N/A Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection February 2015 September 2017
NCT03060733 Completed Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects February 14, 2017 May 14, 2018
NCT03060746 Completed Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects February 14, 2017 May 3, 2018
NCT03065868 Completed Phase 4 Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp December 9, 2015 April 30, 2019
NCT03108287 Completed Phase 4 Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori April 1, 2013 February 28, 2015
NCT03124420 Completed Phase 4 Intraluminal Therapy for Helicobacter Pylori Infection April 28, 2017 April 30, 2018
NCT03165253 Completed N/A The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children June 2011 August 2012
NCT03193450 Completed N/A Telephone-Based Re-education for Hp Eradication October 18, 2017 March 30, 2018
NCT03198507 Completed Phase 3 ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator June 18, 2017 December 13, 2018
NCT03317223 Completed Phase 3 A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients October 17, 2017 January 24, 2019
NCT03324763 Completed Performances of a Fast Test for the Detection of Helicobacter Pylori Antigens in Child Stool March 19, 2014 October 7, 2015
NCT03383003 Completed N/A Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy March 1, 2016 May 1, 2018
NCT03404440 Completed N/A Eradication of Helicobacter Pylori With a Lactobacillus Reuteri Strain Plus Proton Pump Inhibitor January 15, 2016 November 1, 2017
NCT03405584 Completed Phase 4 High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment January 3, 2018 November 2, 2018
NCT03411733 Completed Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris March 1, 2017 March 1, 2018
NCT03413020 Completed Phase 4 Tailored Therapy for Helicobacter Pylori Rescue Treatment January 3, 2018 July 31, 2018
NCT03498456 Completed Phase 3 Triple Therapy With Tegoprazan in H. Pylori Positive Patients June 28, 2018 December 31, 2019
NCT03516669 Completed Phase 4 Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection May 7, 2018 February 8, 2019
NCT03521726 Completed Phase 4 Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection May 11, 2018 February 12, 2019
NCT03524833 Completed Phase 4 Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection May 7, 2018 February 8, 2019
NCT03547544 Completed Rapid Urease Test for Diagnosis Helicobacter Pylori Infection May 28, 2018 December 31, 2018
NCT03557437 Completed Phase 4 High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment May 25, 2018 June 10, 2019
NCT03572777 Completed N/A Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy. April 15, 2018 October 15, 2019
NCT03609892 Completed Phase 4 Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy August 1, 2018 August 20, 2019
NCT03654781 Completed Phase 1 Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication April 21, 2008 February 17, 2012
NCT03658746 Completed Phase 4 Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection January 1, 2019 December 31, 2019
NCT03665428 Completed Phase 4 Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea July 16, 2018 December 31, 2019
NCT03688828 Completed N/A Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori November 11, 2018 December 31, 2020
NCT03708848 Completed Phase 4 Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy December 5, 2018 September 30, 2019
NCT03757650 Completed Phase 4 THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY October 1, 2018 February 1, 2021
NCT03779074 Completed Phase 3 Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies September 3, 2018 December 31, 2021
NCT03779087 Completed N/A Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection July 11, 2018 June 30, 2020
NCT03829150 Completed N/A Dexlansoprazole MR-Based Concomitant Quadruple Therapy March 1, 2017 April 20, 2019
NCT03832465 Completed Phase 4 Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution June 14, 2019 December 27, 2020
NCT03884348 Completed Tailored H. Pylori Eradication Based on Clarithromycin Resistance January 1, 2017 December 31, 2018
NCT03917836 Completed Dysplasia Detection and Helicobacter Pylori Eradication May 30, 2018 April 10, 2019
NCT03968302 Completed Phase 2 ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION June 1, 2018 May 15, 2019
NCT03976739 Completed Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study. June 17, 2019 December 31, 2019
NCT04000243 Completed Diagnosis of Helicobacter Pylori Based on Gastric Collecting Venules July 1, 2019 December 31, 2020
NCT04024527 Completed Phase 4 High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment July 25, 2019 May 24, 2021
NCT04037904 Completed Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication February 2006 December 2022
NCT04039412 Completed Phase 4 Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt June 1, 2018 June 30, 2019
NCT04061447 Completed N/A Tailored Juice-guided Eradication Therapy February 5, 2016 July 31, 2019
NCT04128917 Completed Phase 3 Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT January 21, 2020 January 29, 2021
NCT04132479 Completed Phase 4 The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar January 1, 2018 April 9, 2019
NCT04167670 Completed Phase 3 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection December 10, 2019 March 18, 2021
NCT04178187 Completed N/A The Role of Probiotics in the Eradication of Helicobacter Pylori October 2, 2019 December 31, 2021
NCT04209933 Completed Phase 4 Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies May 25, 2020 August 30, 2020
NCT04233684 Completed N/A Rapid Urease Test for Helicobacter Pylori in Population Who Stop Proton Pump Inhibitor Less Than 2 Weeks Compared With Histology August 1, 2019 February 1, 2021
NCT04237220 Completed Endoscopic Biopsy to Detect Helicobacter Pylori January 25, 2020 May 20, 2020
NCT04296513 Completed Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients March 1, 2020 November 15, 2020
NCT04348786 Completed Phase 4 Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori February 1, 2019 September 1, 2020
NCT04403087 Completed Phase 4 Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications May 1, 2021 July 1, 2021
NCT04445948 Completed Phase 4 Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy November 30, 2019 June 21, 2020
NCT04473079 Completed Phase 2/Phase 3 Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia October 16, 2020 June 17, 2022
NCT04525664 Completed Early Phase 1 Assessment and Management of Chronic Dyspepsia in Eastern Uganda October 1, 2018 June 30, 2020
NCT04531059 Completed Phase 4 Rescue Therapy for Helicobacter Pylori Eradication October 15, 2020 December 31, 2022
NCT04617613 Completed Phase 4 Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait September 2016 December 2019
NCT04621487 Completed N/A Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection January 15, 2019 February 15, 2020
NCT04636866 Completed The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019 February 10, 2020 September 16, 2020
NCT04660123 Completed Phase 4 A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication December 20, 2020 December 30, 2021
NCT04678492 Completed Phase 4 Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy December 20, 2020 December 20, 2021
NCT04697186 Completed Phase 4 Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy January 7, 2021 December 20, 2021
NCT04697641 Completed N/A Helicobacter Pylori Eradication in Functional Dyspepsia September 1, 2017 May 31, 2019
NCT04708405 Completed The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observation September 10, 2019 October 30, 2020
NCT04850209 Completed N/A The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori July 23, 2021 September 10, 2022
NCT04853875 Completed Phase 4 ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin April 19, 2021 December 16, 2022
NCT04879992 Completed N/A Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori May 7, 2021 October 30, 2022
NCT04892238 Completed Helicobacter Pylori Infection Occurrence in Russia January 1, 2017 July 31, 2020
NCT04901663 Completed Phase 4 Vonoprazan in Helicobacter Pylori Treatment an RCT June 21, 2021 August 16, 2021
NCT04918134 Completed Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province July 10, 2021 October 7, 2021
NCT04923113 Completed N/A Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis June 28, 2021 January 18, 2023
NCT05014334 Completed Phase 4 Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication December 1, 2021 June 30, 2022
NCT05035186 Completed N/A Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era March 21, 2021 November 30, 2021
NCT05049902 Completed Phase 4 Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication September 21, 2021 June 30, 2023
NCT05152004 Completed N/A Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment September 1, 2018 February 28, 2022
NCT05173493 Completed The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure December 30, 2021 February 10, 2023
NCT05191875 Completed N/A Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori December 1, 2021 April 23, 2022
NCT05227079 Completed N/A Assessing the Histological Quality of Biopsy Samples Obtained With Multibite Forceps May 1, 2022 July 30, 2023
NCT05297695 Completed Phase 2/Phase 3 Helicobacter Pylori Eradication Therapy for Epileptic Children April 20, 2022 December 30, 2023
NCT05342532 Completed Phase 4 High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population June 12, 2019 January 1, 2022
NCT05349578 Completed N/A Gastric Swab for Helicobacter Pylori Detection March 1, 2021 March 1, 2022
NCT05374980 Completed N/A The Effects of Yogurt on Gut Microbiome and Metabolism in H. Pylori. January 1, 2022 February 16, 2023
NCT05399862 Completed N/A The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults December 24, 2020 January 10, 2022
NCT05410652 Completed Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method) August 1, 2022 October 1, 2023
NCT00132171 Completed Phase 3 Helicobacter Pylori Eradication With a New Sequential Treatment January 2001 December 2001
NCT05469685 Completed Phase 4 Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication August 1, 2022 September 30, 2023
NCT05577468 Completed Phase 3 Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori October 30, 2022 September 30, 2023
NCT05664685 Completed Phase 4 Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication October 17, 2022 January 30, 2024
NCT05701683 Completed Phase 4 IMPROVEMENT in ERADICATION of H-PYLORI INFECTION November 15, 2019 December 31, 2022
NCT05861687 Completed Phase 2/Phase 3 Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children August 1, 2021 May 20, 2022
NCT05863858 Completed Phase 3 Eradication of H. Pylori Infection With Moxifloxacin June 1, 2020 June 8, 2022
NCT05901051 Completed Phase 4 High-dose Dual Therapy With Different Administration Frequencies March 30, 2021 September 30, 2023
NCT05969444 Completed Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study. June 1, 2015 March 6, 2023
NCT06076681 Completed Phase 1/Phase 2 A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules September 27, 2021 January 6, 2022
NCT06076694 Completed Phase 2 Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants June 26, 2022 September 20, 2022
NCT06081699 Completed Phase 1 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants May 9, 2019 September 18, 2019
NCT06081712 Completed Phase 1 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection October 20, 2020 July 15, 2021
NCT06137573 Completed Phase 1 Human Mass Balance and Biotransformation Study of [14C]TNP-2198 July 12, 2022 September 1, 2022
NCT06190340 Completed Phase 1 A Phase 1, Multiple Oral Administrations of TNP-2092 Capsules in Asymptomatic Healthy People With Helicobacter Pylori Infection November 7, 2016 August 15, 2017
NCT06250634 Completed N/A Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection February 10, 2024 May 10, 2024
NCT06282484 Completed A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions September 1, 2022 September 29, 2023
NCT06332599 Completed Minocycline for Helicobacter Pylori Rescue Treatment March 1, 2021 April 30, 2024
NCT06337604 Completed Phase 1 The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets October 10, 2017 November 23, 2017
NCT06399562 Completed Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province April 20, 2024 April 30, 2024
NCT06414707 Completed Phase 3 Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori October 12, 2023 April 4, 2024
NCT05475431 Enrolling by invitation Real-world Treatment of H. Pylori Eradication in Patients With Comorbidity May 6, 2020 December 31, 2023
NCT04527055 Enrolling by invitation Phase 4 The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication May 6, 2020 July 31, 2028
NCT05320133 Enrolling by invitation N/A Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection June 20, 2022 December 31, 2024
NCT06216639 Enrolling by invitation Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection February 1, 2024 January 2025
NCT06299605 Not yet recruiting N/A Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori March 2024 November 2024
NCT05586464 Not yet recruiting Phase 1 Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine November 1, 2022 September 30, 2024
NCT06200779 Not yet recruiting Phase 4 Tailored vs. Empirical Helicobacter Pylori Infection Treatment September 2024 November 2025
NCT05810805 Not yet recruiting Measurement and Analysis of Gas Composition in Digestive Tract April 1, 2023 March 2, 2024
NCT05620602 Not yet recruiting The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection November 11, 2022 December 31, 2024
NCT06421324 Not yet recruiting N/A Personalised Health Recommendations to the General Population Through an Integrated AI Guided June 1, 2024 December 31, 2026
NCT06273384 Not yet recruiting Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding March 1, 2024 December 31, 2024
NCT05438550 Not yet recruiting Phase 4 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection February 14, 2023 December 31, 2023
NCT05658055 Not yet recruiting Phase 4 The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication June 1, 2023 December 31, 2023
NCT06351891 Not yet recruiting Phase 4 Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin April 2024 December 2024
NCT06065267 Not yet recruiting Phase 4 Levofloxacin Concomitant Versus Levofloxacin Sequential January 2, 2024 June 30, 2027
NCT06037122 Not yet recruiting Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication September 2023 June 2024
NCT05662514 Not yet recruiting N/A Effect of Probiotics on Gut Microbiota During the Helicobacter Pylori Eradication February 15, 2023 January 15, 2024
NCT06318104 Not yet recruiting Phase 4 Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole April 19, 2024 February 28, 2025
NCT05726734 Not yet recruiting Phase 4 Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial February 6, 2023 February 6, 2026
NCT06340334 Not yet recruiting N/A Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study March 2024 December 31, 2024
NCT05483660 Not yet recruiting Phase 2 A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection August 1, 2022 August 31, 2024
NCT05493644 Not yet recruiting A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure September 1, 2022 December 31, 2023
NCT05879237 Not yet recruiting N/A Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children June 1, 2023 December 10, 2023
NCT06340724 Not yet recruiting Early Phase 1 Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication March 2024 March 2025
NCT06412588 Not yet recruiting N/A Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication:A Prospective, Multicenter, Open-label Randomized Controlled Study. May 2024 December 31, 2024
NCT05620589 Not yet recruiting The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection November 11, 2022 December 31, 2024
NCT05586113 Not yet recruiting Phase 4 The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial February 6, 2023 December 31, 2023
NCT05121025 Recruiting Pathogen-microbiome Interaction During Helicobacter Pylori Infection March 11, 2022 June 1, 2025
NCT05024864 Recruiting N/A HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in MI Patients November 17, 2021 January 17, 2030
NCT05455372 Recruiting N/A Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy July 8, 2022 March 31, 2024
NCT05461508 Recruiting Phase 1/Phase 2 Fucoidan Assisted Eradication of Helicobacter Pylori October 1, 2022 July 31, 2024
NCT05649540 Recruiting Phase 4 Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori January 20, 2023 December 1, 2024
NCT06228963 Recruiting Phase 2 Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma March 2024 January 2028
NCT05046990 Recruiting Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori December 1, 2021 September 30, 2023
NCT05495854 Recruiting N/A New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool February 3, 2023 February 3, 2024
NCT05830357 Recruiting Prevalence and Risk Factors of Helicobacter Pylori Infection in Children and Young Adults May 1, 2023 September 30, 2023
NCT05870683 Recruiting N/A Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301） May 24, 2023 December 30, 2023
NCT05874544 Recruiting Phase 4 Rescue Therapy for Helicobacter Pylori Infection May 16, 2023 December 31, 2024
NCT05762991 Recruiting Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion December 24, 2021 December 31, 2026
NCT05775120 Recruiting Epidemiology of Helicobacter Pylori Infection in Moscow July 1, 2022 January 15, 2025
NCT06382493 Recruiting N/A Tegoprazan-containing Sequential for H. Pylori February 1, 2021 December 12, 2024
NCT05874570 Recruiting Phase 4 Doxycycline for Helicobacter Pylori Rescue Treatment June 20, 2023 December 31, 2024
NCT05247112 Recruiting Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea July 1, 2003 December 31, 2027
NCT05926804 Recruiting N/A A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile August 2, 2022 March 31, 2026
NCT05787262 Recruiting N/A Clinical Utility of Upper Endoscopy in Diagnosis of Helicobacter Pylori Infection March 1, 2023 March 1, 2024
NCT06088316 Recruiting Phase 4 Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT February 10, 2023 February 2024
NCT05933031 Recruiting Phase 2 Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients February 27, 2023 December 31, 2024
NCT05718609 Recruiting Phase 4 Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection March 1, 2023 June 30, 2024
NCT05802732 Recruiting Stool Antigen In Diagnosis Of Helicobacter Pylori January 1, 2023 April 2024
NCT05957432 Recruiting Phase 2 Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori August 15, 2023 August 2024
NCT06422052 Recruiting Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms March 11, 2024 May 31, 2025
NCT05332444 Recruiting Phase 4 Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection April 11, 2022 December 2025
NCT04147065 Recruiting Phase 4 Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study) July 14, 2021 March 30, 2025
NCT06391177 Recruiting Phase 1 A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily June 3, 2024 August 2024
NCT05802888 Recruiting Phase 4 Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies. March 12, 2023 June 15, 2024
NCT06143124 Recruiting Phase 4 Bismuth Quadruple Therapy Versus Standard Triple Therapy March 3, 2022 November 3, 2025
NCT05364619 Recruiting N/A Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection August 5, 2022 December 31, 2024
NCT06156085 Recruiting Phase 4 Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy November 14, 2023 December 31, 2025
NCT05654857 Recruiting The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu March 1, 2023 August 30, 2023
NCT05728424 Recruiting Phase 3 One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL September 20, 2022 May 1, 2023
NCT05997433 Recruiting N/A Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302) September 2, 2023 August 30, 2024
NCT05432115 Recruiting Phase 4 Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies. June 25, 2022 October 2023
NCT05846061 Recruiting Epidemiology of Helicobacter Pylori Infection in Children From Slovenia January 9, 2021 June 9, 2023
NCT03897244 Recruiting Phase 4 Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication May 30, 2019 December 2024
NCT04191551 Recruiting The GAstric Precancerous Conditions Study July 30, 2018 June 30, 2026
NCT05590286 Recruiting Phase 4 A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection June 1, 2022 December 31, 2024
NCT05614934 Recruiting Phase 4 Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management June 11, 2022 March 15, 2023
NCT04415983 Recruiting Phase 3 Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children June 1, 2020 December 1, 2030
NCT05681689 Recruiting Phase 3 PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study December 21, 2022 June 2023
NCT05061732 Recruiting Phase 4 Helicobacter Pylori Eradication and Follow-up September 30, 2021 June 30, 2026
NCT05527496 Recruiting Effect of Hp Infection on the Quality of Gastric Mucosa Preparation August 1, 2022 August 31, 2023
NCT05549115 Recruiting N/A Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection September 20, 2022 February 2024
NCT05561504 Recruiting Helicobacter Pylori Local Prevalence and Antibiotic Resistance March 31, 2021 December 31, 2035
NCT05742568 Recruiting Phase 4 Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology December 1, 2022 March 10, 2024
NCT06397066 Recruiting White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection May 1, 2024 June 30, 2025
NCT04723472 Suspended N/A Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment August 1, 2023 December 31, 2025
NCT01109381 Terminated Phase 1/Phase 2 Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori May 2010 December 2011
NCT03925818 Terminated N/A Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication August 29, 2017 December 23, 2018
NCT01575899 Terminated Phase 4 Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori December 2007 December 2009
NCT04025983 Terminated N/A Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection November 1, 2019 October 1, 2021
NCT01643785 Terminated N/A Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection June 2012 June 2013
NCT03837990 Unknown status One Sequencing Find All for Helicobacter Pylori Infection May 1, 2019 December 31, 2019
NCT03908619 Unknown status Phase 4 A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis April 16, 2019 March 31, 2021
NCT03973242 Unknown status N/A Dual-focus Magnification With Narrow-band Imaging in Helicobacter Pylori Infection March 15, 2018 March 31, 2020
NCT03997279 Unknown status Phase 4 Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii June 2019 June 2020
NCT04122287 Unknown status Phase 4 Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin November 1, 2019 December 2022
NCT04212585 Unknown status The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital January 1, 2021 January 1, 2022
NCT04264663 Unknown status Phase 4 Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin November 1, 2019 December 30, 2022
NCT04319991 Unknown status N/A The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection November 15, 2019 November 2021
NCT04332848 Unknown status Phase 4 Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection July 24, 2020 March 2023
NCT04359966 Unknown status N/A Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia May 10, 2020 September 30, 2023
NCT00441831 Unknown status The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy February 2007 February 2008
NCT04432233 Unknown status Phase 4 Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease June 15, 2020 June 15, 2021
NCT01071759 Unknown status Effects of Dietary Heme/Non-heme Iron and Helicobacter Pylori (Hp) Infection on Maternal Iron-deficiency Anemia and Fetal Growth Outcomes February 2009
NCT01115296 Unknown status N/A Control of Helicobacter Pylori Infection by Probiotics January 2010 August 2012
NCT04566211 Unknown status N/A Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy. January 1, 2020 December 31, 2022
NCT01265069 Unknown status Phase 4 Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy November 2010 December 2013
NCT04626193 Unknown status Phase 4 LOAD VS Levofloxacine Concomitant October 31, 2020 May 30, 2024
NCT01464060 Unknown status Phase 4 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication September 2011 January 2013
NCT01486082 Unknown status Antimicrobial Susceptibility for Helicobacter Pylori Eradication February 2011 May 2012
NCT04667299 Unknown status Phase 4 Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment December 20, 2020 December 31, 2021
NCT01566643 Unknown status Phase 4 Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections January 2011 December 2012
NCT04674774 Unknown status N/A Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection March 4, 2021 March 31, 2022
NCT01028690 Unknown status N/A Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri December 2009 January 2012
NCT01816269 Unknown status Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection March 2013 May 2013
NCT04728516 Unknown status Phase 4 The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients August 10, 2021 June 30, 2023
NCT01906879 Unknown status Phase 4 Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection June 2013 December 2017
NCT04901117 Unknown status Phase 4 Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days June 2021 August 2023
NCT02108184 Unknown status Phase 4 Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy February 2014 August 2016
NCT00990405 Unknown status Phase 4 Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia October 2009 December 2010
NCT04907747 Unknown status Phase 4 Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication May 18, 2021 April 13, 2022
NCT02249546 Unknown status Phase 4 Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection September 2014 October 2016
NCT02368470 Unknown status Phase 3 Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection February 2015 October 2015
NCT00985608 Unknown status Phase 2 Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study April 2009 September 2009
NCT04984382 Unknown status N/A Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists July 26, 2021 September 2022
NCT04989153 Unknown status Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer March 5, 2016 December 6, 2023
NCT04991584 Unknown status N/A Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection August 4, 2021 July 1, 2022
NCT05014685 Unknown status Phase 4 PPI-amoxicillin for H. Pylori Treatment August 20, 2021 December 30, 2022
NCT05018923 Unknown status Phase 4 Tetracycline Versus Doxycycline for HP Rescue Therapy August 24, 2021 December 30, 2022
NCT05023577 Unknown status Phase 4 Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients August 26, 2021 December 30, 2022
NCT02635191 Unknown status Phase 4 Tailored Therapy for Helicobacter Pylori in Children March 2014 July 2016
NCT02654197 Unknown status Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children June 2016 May 2019
NCT05065138 Unknown status N/A Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists September 22, 2021 September 2022
NCT05097846 Unknown status N/A Differences in the Eradication of Helicobacter Pylori by Different Therapies June 17, 2021 October 17, 2022
NCT02759029 Unknown status N/A Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test March 2016 February 2018
NCT05100446 Unknown status Early Phase 1 Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection May 1, 2021 December 31, 2022
NCT02894268 Unknown status Phase 4 Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy February 2016 December 2019
NCT05126121 Unknown status N/A Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection November 20, 2021 December 30, 2022
NCT05129176 Unknown status Phase 4 Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin November 23, 2021 November 2022
NCT05133193 Unknown status N/A Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection November 20, 2021 June 30, 2022
NCT05135182 Unknown status Phase 4 Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin November 28, 2021 December 2022
NCT02961296 Unknown status Helicobacter Pylori Antibiotic Susceptibility Testing of Korea October 2016 December 2018
NCT05189444 Unknown status N/A The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori March 25, 2022 December 31, 2022
NCT02988089 Unknown status Phase 4 Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment April 20, 2017 September 2017
NCT03011437 Unknown status Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging December 2016 January 2017
NCT03057171 Unknown status A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA May 2015 April 2020
NCT05226819 Unknown status N/A Influencing Factors of Helicobacter Pylori Infection and Eradication Failure February 6, 2022 March 2023
NCT03099876 Unknown status A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients March 1, 2017 December 1, 2018
NCT05250050 Unknown status Phase 4 Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment March 25, 2022 March 1, 2023
NCT03130452 Unknown status Phase 4 Helicobacter Pylori Eradication Study February 1, 2017 May 31, 2018
NCT03134378 Unknown status Phase 4 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication October 3, 2016 May 12, 2017
NCT03150394 Unknown status Phase 4 Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice. April 4, 2017 August 2018
NCT05259007 Unknown status Phase 4 Effect of Propolis on Patients Infected With H. Pylori February 22, 2022 April 5, 2022
NCT03208426 Unknown status Phase 4 Sequential Versus Quadruple Therapy in the Second-line Treatment October 1, 2017 December 31, 2020
NCT03220542 Unknown status Phase 4 The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori January 2016 December 31, 2019
NCT03297242 Unknown status Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients December 2017 September 2018
NCT03299725 Unknown status Phase 4 Bismuth Based Quadruple Therapy 10 Days in Children November 24, 2017 November 2019
NCT03310255 Unknown status Helicobacter Pylori Infection in Renal Transplant Patients November 1, 2017 February 28, 2019
NCT05329636 Unknown status Phase 1/Phase 2 Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy September 26, 2018 December 1, 2023
NCT03321773 Unknown status N/A Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy January 2017 December 2020
NCT03361267 Unknown status N/A Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection December 30, 2017 June 28, 2018
NCT03397680 Unknown status Phase 1 Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia May 15, 2017 May 15, 2018
NCT00155389 Unknown status Phase 4 Community-based Helicobacter Pylori Eradication January 2004 December 2015
NCT03431688 Unknown status N/A Tailored Therapy for Clarithromycin-Resistant H. Pylori October 1, 2018 December 30, 2020
NCT05410223 Unknown status N/A Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection April 6, 2021 December 1, 2022
NCT05419674 Unknown status Phase 4 Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection August 1, 2022 August 1, 2023
NCT03556254 Unknown status Phase 4 Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori March 29, 2018 June 30, 2022
NCT03565484 Unknown status Phase 4 Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection January 1, 2019 June 30, 2020
NCT03571230 Unknown status Phase 4 Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication. July 1, 2018 January 30, 2020
NCT03583476 Unknown status The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection. April 1, 2018 December 31, 2018
NCT03616405 Unknown status Phase 4 Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection April 1, 2019 April 30, 2020
NCT03658733 Unknown status Phase 4 A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection December 15, 2018 October 31, 2019
NCT03722433 Unknown status Phase 4 Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication August 29, 2018 July 31, 2020
NCT03726099 Unknown status Phase 4 Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection March 15, 2019 December 30, 2020
NCT03730766 Unknown status Phase 4 Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults August 1, 2018 November 20, 2018
NCT03802318 Unknown status N/A Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication January 2, 2019 December 2020
NCT04006340 Unknown status N/A Empirical vs Tailored Therapy for H. Pylori Infection January 4, 2019 August 31, 2019
NCT00455806 Unknown status Phase 3 Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection January 2007 February 2008
NCT04090021 Unknown status Phase 4 Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication. September 1, 2019 February 28, 2020
NCT04107194 Unknown status Phase 3 Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. January 14, 2020 April 14, 2022
NCT04462133 Withdrawn N/A Optimal Tailored Treatment for H. Pylori Infection September 1, 2020 October 1, 2024
NCT02552641 Withdrawn Phase 4 Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole September 2015 September 2016
NCT00765401 Withdrawn An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients November 2008 April 2011
NCT01252108 Withdrawn Phase 2 Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers March 2012 August 2015
NCT00712413 Withdrawn Phase 3 Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori August 2008 December 2008
NCT03146325 Withdrawn Phase 4 Helicobacter Pylori and Body Iron in Adults November 2012 August 2016
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0005202
MedGen concept unique identifier (MedGen Concept name)
C0850666
MedGen unique identifier (MedGen Concept name)
208857